DeepNoid Inc
KOSDAQ:315640
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DeepNoid Inc
Cash Equivalents
DeepNoid Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DeepNoid Inc
KOSDAQ:315640
|
Cash Equivalents
₩4B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Cash Equivalents
-₩500
|
CAGR 3-Years
92%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Cash Equivalents
₩10.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
1%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Cash Equivalents
₩19.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
J
|
JLK Inc
KOSDAQ:322510
|
Cash Equivalents
₩9.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
DeepNoid Inc
Glance View
Deepnoid, Inc. operates artificial intelligence medical imaging analytics platform. The company is headquartered in Seoul, Seoul and currently employs 115 full-time employees. The company went IPO on 2021-08-17. The firm a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The firm's main products include DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS.
See Also
What is DeepNoid Inc's Cash Equivalents?
Cash Equivalents
4B
KRW
Based on the financial report for Dec 31, 2024, DeepNoid Inc's Cash Equivalents amounts to 4B KRW.
What is DeepNoid Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
41%
Over the last year, the Cash Equivalents growth was -81%. The average annual Cash Equivalents growth rates for DeepNoid Inc have been -37% over the past three years , 41% over the past five years .
